Testing a Potential Therapeutic Target for Lymphoma
This study investigates a new therapeutic target (valosin-containing protein) for dogs with lymphoma.
Determining the Prognostic Value of Identifying Genetic Mutations in Dogs with Lymphoma
Researchers will assess the value of a genetic prognostic tool to assist with treatment decisions for dogs with diffuse large B-cell lymphoma.
Measuring Chemotherapy Drug Resistance in Dogs with T-cell Lymphoma
Researchers will measure changes in circulating cancerous T-cells in dogs with lymphoma to gauge chemotherapy drug resistance and tailor treatments for individual patients with this aggressive and common cancer.
Evaluating the Effectiveness of an Adjunct Therapy in Dogs with Osteosarcoma
Researchers are evaluating the effectiveness of oral rapamycin as an adjunct, postsurgery therapy to combat cancer spread (metastasis) in client-owned dogs.
Identifying a Signaling Pathway with Potential to Treat Melanoma
This study investigates the therapeutic relevance of targeting the Wnt signaling pathways in canine malignant melanoma.
Determining Whether Probiotics Reduce the Side Effects of Chemotherapy
This study will evaluate whether an oral probiotic protects the gastrointestinal tract from the toxic effects of a chemotherapy drug regimen for dogs.